Foamix Pharmaceuticals Ltd. Accounts Receivable
Foamix Pharmaceuticals Ltd. had Accounts Receivable of $135.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2020-03-12
- 2019-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $135.00K.
- 2019-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $308.00K.
- 2019-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $1.17M.
- 2018-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $1.07M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2019-12-31 | $135.00K 10-K · filed 2020-03-12 |
| 2019-06-30 | $308.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.17M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $1.07M 10-K · filed 2020-03-12 |
| 2018-09-30 | $889.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $975.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $846.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $996.00K 10-K · filed 2019-02-28 |
| 2017-06-30 | $798.00K 6-K · filed 2017-08-08 |
| 2016-12-31 | $3.24M 10-K · filed 2018-03-01 |
| 2016-06-30 | $754.00K 6-K · filed 2016-08-10 |
| 2015-12-31 | $314.00K 20-F · filed 2017-02-21 |
| 2015-06-30 | $135.00K 6-K · filed 2015-10-19 |
| 2014-12-31 | $495.00K 20-F · filed 2016-03-02 |
| 2013-12-31 | $425.00K 20-F · filed 2015-03-17 |